Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA panel to consider weight gain and heart risk versus benefits of Seroquel for depression
FDA panel to consider weight gain and heart risk versus benefits of Seroquel for depression
FDA panel to consider weight gain and heart risk versus benefits of Seroquel for depression
Submitted by
admin
on April 8, 2009 - 8:30am
Source:
Yahoo/AP
News Tags:
FDA
Seroquel
AstraZeneca
depression
schizophrenia
Headline:
FDA panel to consider weight gain and heart risk versus benefits of Seroquel for depression
Do Not Allow Advertisers to Use My Personal information
